| Similar Articles |
|---|
 |
Nursing Management
May 2009
Dawn M. Pope et al. |
MRSA Reduction: Myths and Facts To prevent the spread of MRSA, organizations must commit to implementing evidence-based guidelines and providing ongoing education to address misconceptions and individual attitudes.   |
American Family Physician
December 15, 2005
Bamberger & Boyd |
Management of Staphylococcus aureus Infections Because of high incidence, morbidity, and antimicrobial resistance, Staphylococcus aureus infections are a growing concern for family physicians. |
Nursing
March 2010
Delahanty & Myers |
3 bad bugs Acinetobacter baumannii, Panton-Valentine leukocidin positive methicillin-resistant Staphylococcus aureus, and infections that develop as a result of antimicrobial therapy, such as Clostridium difficile. |
Chemistry World
April 2, 2013
Emma Stoye |
New diagnostic test lights up bacteria UK researchers have developed a faster way to detect Staphylococcus aureus bacteria using a fluorescent probe. The method holds promise as the basis for a new rapid diagnosis kit to identify infections in hospital patients. |
Nursing Management
May 2011
Kirsten Drake |
SCIP core measures: Deep impact In August 2005, the SIP project grew to become a multiyear, national quality partnership of organizations called the Surgical Care Improvement Project, or SCIP, with the goal of decreasing surgical complication by 25% by 2010. |
American Family Physician
February 15, 2002
Paul W. Ament |
Linezolid Its role in the treatment of gram-positive, drug-resistant bacterial infections... |
American Family Physician
December 1, 2001
John P. Manzella |
Quinupristin-Dalfopristin: A New Antibiotic for Severe Gram-Positive Infections Quinupristin-dalfopristin is a streptogramin. This class of antibiotics is an important addition to the options available for the treatment of severe infections caused by gram-positive organisms... |
American Family Physician
March 15, 2001
Thomas Hooton & Stuart Levy |
Antimicrobial Resistance: A Plan of Action for Community Practice Antibiotic resistance was once confined primarily to hospitals but is becoming increasingly prevalent in family practice settings, making daily therapeutic decisions more challenging. |
Managed Care
December 2007
Lola Butcher |
Insurers Get Involved in Campaign Against Hospital-Acquired Infections Health plans prod hospitals to do a better job of addressing problems that kill nearly 100,000 Americans a year. |
American Family Physician
January 15, 2001
Charles P. Mouton |
Common Infections in Older Adults Despite advances in antibiotic therapy, infectious diseases continue to be a major cause of mortality in older adults. The diagnostic and therapeutic nuances of managing infections in older adults create special challenges for physicians... |
The Motley Fool
January 3, 2008
Brian Orelli |
A Super Superbug Testing Market Becton, Dickinson gets FDA approval of its quick blood test for MRSA, the so-called superbug. |
BusinessWeek
April 12, 2004
Catherine Arnst |
Killer Staph Is Hitting The Streets For the past 30 years, hospitals have been battling a mutant form called methicillin-resistant S. aureus (MRSA) that is resistant to penicillin-related antibiotics and is especially lethal. Now it's showing up in the general population. |
Scientific American
January 2007 |
Meet Resistance Head-On With resistance to antibiotics growing at an alarming pace among pathogenic bacteria, Americans must become more aggressive with regard to early intervention in the processes that foster resistance. |
Nursing Management
March 2010
Becker & Schmidtke |
All along the watchtower: Suicide risk screening, a pilot study Patients will continue to die if healthcare organizations don't take action and appropriately assess patients at risk for suicide in general hospitals. |
AskMen.com
Jacob Franek |
Superbugs So long as antibiotic use remains widespread and excessive, superbug bacteria will be here with us. Read on about some of the most common North American superbugs. |
Chemistry World
January 16, 2011
Hayley Birch |
Antibodies could lead to MRSA vaccine US scientists have developed antibodies against a protein belonging to methicillin-resistant Staphylococcus aureus bacteria. |
American Family Physician
July 1, 2002
Daniel L. Stulberg |
Common Bacterial Skin Infections Family physicians frequently treat bacterial skin infections in the office and in the hospital. Knowledge of the presentation, histopathology, and microbiology for each type of infection is important for proper care of the patient. |
BusinessWeek
October 29, 2007
Catherine Arnst |
Superbugs: Where Are the Wonder Drugs? Antibiotics are losing the battle against superbugs, and drugmakers are slow to replenish the arsenal. |
Nursing
March 2012
Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
Health
June 19, 2009
Ginny Graves |
How to Combat the Latest Supergerms While some germs may be outpacing our ability to kill them, we're not completely defenseless. In fact, there are plenty of things we can do to slow their spread. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
BusinessWeek
June 9, 2009
John Carey |
Giving Patients the Data They Need A growing effort by doctors, insurers, and politicians helps people make better-informed medical decisions |
Health
March 2008
Jilly Jackson |
The Truth About Staph One woman's harrowing tale of dealing with a dangerous infection called MRSA. How she got it, how it spread, and how she's doing now. |
Bio-IT World
Jul/Aug 2006
Robert M. Frederickson |
Tests for Hospital-Acquired Infections Tests for pathogens increasingly rely on genomic methods that identify specific genetic signatures of bacteria or viruses. Rapid detection of other pathogens also provides the potential for significant impact on the healthcare industry. |
Reactive Reports
Issue 57
David Bradley |
A Spoonful of Slime Helps the Medicine Go Down The slime that covers the flat-fish plaice contains an antimicrobial agent that kills Staphylococcus aureus, the bacteria causing concern in hospitals across the globe as its drug-resistant strains spread. |
Pharmaceutical Executive
October 1, 2008
Michael Bonney |
Specialty Sales Gets No Resistance The author, a Cubist Pharmaceuticals CEO. has given his company a successful start and is now predicting the future of drug resistance. |
American Family Physician
November 15, 2005
Haas et al. |
Management of the Difficult Patient All physicians must care for some patients who are perceived as difficult because of behavioral or emotional aspects that affect their care. Specific communication techniques and greater patient involvement in the process of care may enhance the relationship. |
Chemistry World
September 19, 2008
John Bonner |
Filling the antibiotic gap Resistance to currently available antibacterial drugs is causing growing concern among doctors who find themselves unable to treat common infections |
Chemistry World
March 15, 2012
Andrew Shore |
Designer solvent hits hospital superbug Scientists from Ireland, the Czech Republic and Spain have found an antimicrobial ionic liquid that targets MRSA (methicillin-resistant Staphylococcus aureus). |
Fast Company
May 2009
Elizabeth Svoboda |
Biotechs Wage War on Superbugs With antibiotic resistance on the rise, three biotechs are developing new ways to wage war on superbugs. |
BusinessWeek
November 12, 2009
Catherine Arnst |
10 Ways to Cut Health-Care Costs Right Now Employers and hospitals don't have to wait for Congress to address inefficiencies and waste. |
Chemistry World
August 2, 2012
Yuandi Li |
Cleaning hands with light A quick way to kill methicillin resistant Staphylococcus aureus and other pathogens using a photosensitiser and visible light can be used to clean hands, say scientists in Germany. |
Pharmaceutical Executive
January 1, 2006
Maggie Helmig |
Direct to Consumer: Patient Education Reform Marketers can empower patients to start a dialogue with their doctors. |
Chemistry World
August 11, 2014
Phillip Broadwith |
Single shot antibiotic approved for skin infections Intravenous antibiotic Orbactiv oritavancin, from US firm The Medicines Company, has been approved by the US Food and Drug Administration. |
Chemistry World
July 15, 2010
Matt Wilkinson |
Biotechs plot path of least resistance Biopharmaceutical companies are moving into antibiotics, and filling the void left by big pharma. |
The Motley Fool
May 12, 2004
Charly Travers |
Cubist Addresses a Niche Market This small firm is developing antibiotics to meet a medical need. |
Reactive Reports
Issue 73
David Bradley |
Gator Aid It's perhaps not the first place you would think to search for superbug-beating antibiotics, but alligator's blood could be a great source of novel compounds that could defeat strains of bacteria resistant to conventional antibiotics. |
